CHICAGO, June 18, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the Noble Capital Markets Consumer, Communications, Media, and Technology Emerging Growth Virtual Equity Conference on Wednesday, June 26, 2024, at 2:00 p.m. Eastern Time. A live webcast of the presentation may be accessed through a link that will be posted on GoHealth's Investor Relations website, https ...

Jose Luis Pelaez Inc/DigitalVision via Getty Images GoHealth (NASDAQ:GOCO) is a large-scale broker of insurance products, especially the popular Medicare Advantage plans in which Medicare benefits are delivered by a private insurer, although the company brokers for Medicare supplement plans and other insurance product lines as well. The basic outline of the business model is this: consumers looking for a Medicare plan that best suits their needs can face a vast ocean of choices, with a range of benefit opti ...

CHICAGO, May 22, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced the company will present at the William Blair Growth Stock Conference on Wednesday, June 5, 2024, at 4:20 p.m. Eastern Time. A live webcast of the presentation may be accessed through a link that will be posted on GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay will be available through the same link ...

Financial Performance - Q1'24 Cash Adjusted EBITDA was $70 million, compared to $78 million in Q1'23[16] - The company reported a $74 million improvement in Quarter-End Cash Adjusted EBITDA[14] - Q1'24 Adjusted Gross Margin per Submission was $216, an 7% improvement compared to $202 in Q1'23[20] - Sales per Submission increased by 8% from $794 in Q1'23 to $856 in Q1'24[20] - Cost per Submission increased by 8% from $592 in Q1'23 to $640 in Q1'24[20] Revenue and Adjusted EBITDA - Q1'24 TTM Reported Revenue was $734.4 million, a decrease from $737.1 million in Q1'23 TTM[39] - Q1'24 TTM Reported Adjusted EBITDA was $71.9 million, an increase from $73.2 million in Q1'23 TTM[39] - Q1'24 Net revenues were $185.6 million, compared to $183.158 million in Q1'23[55] - Adjusted EBITDA for Q1'24 was $26.894 million, compared to $28.778 million in Q1'23[55] Non-GAAP Measures - The company uses non-GAAP financial measures, including Adjusted EBITDA and Cash Adjusted EBITDA, to evaluate performance[37] - Cash Adjusted EBITDA equals Adjusted EBITDA plus or minus the year-over-year change in net contract assets[45]

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ (State or other jurisdictio ...

Regulatory Updates "Our first quarter results exceeded our expectations and highlight our team's ability to be innovative and resilient amongst market conditions. The proactive work we have done to drive consumer centricity has been instrumental in our ability to navigate the ever- evolving regulatory landscape. Our model is aligned with CMS's intentions to protect consumers, and the work we have done has prepared us well for the current regulations and those likely to come," said Vijay Kotte, CEO of GoHeal ...

CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights First quarter 2024 net revenues of $185.6 million, a slight increase compared to $183.2 million in the prior year period.First quarter 2024 Submissions of 216,148, a 2,503 increase compared to 213,645 Submissions in the prio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the fiscal year ended December 31, 2023 WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (State or ot ...

"As we reflect on our achievements this past year, our consumer-centric focus shifted from enrollment to engagement, with trust at its core. Our innovative PlanFit CheckUp program is a prime example of our commitment to the consumer and a driver of our 2023 results. By prioritizing the real needs of Medicare consumers, we continue to enhance consumer trust and set a new standard for industry practices, said Vijay Kotte, CEO of GoHealth. "Our approach underscores our mission to transform the consumer healthc ...

For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Commission File Number: 001-39390 GoHealth, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware 85-0563805 (St ...